A Phase I, Randomized, Open-Label, Active Controlled, Multi-Center Pilot Study to Compare Reference to Reference Pharmacodynamics of BOTOX® (onabotulinumtoxinA) in Healthy Subjects. Protocol: MR 103A-0I-IPS-1001. lnformed Consent Form Version Dated 25 November 2022.,
Role: Investigator,
Mylan Pharmaceuticals,
(11/2023 - 03/2024)
Status: Completed
Evaluation of the safety and pharmacodynamic effect of AGN-151607 by measuring the compound muscle action potential (CMAP) of the extensor digitorum brevis ( EDB) muscle following a single injection in healthy subjects. Protocol 1925-101-008, dated 18 August 2017. Informed consent form version dated 30 August 2017,
Role: Investigator,
Allergan Inc.,
(08/2018 - 08/2019)
Status: Completed
Internal
First Time Seizure Clinic,
Role: Investigator,
LLU Dept. of Neurology,
(06/2022)
Status: Completed
Intraneural facilitation as a treatment for carpal tunnel syndrome: A pilot study,
Role: Investigator,
LLU Dept. of Neurology,
(09/2019 - 09/2020)
Status: Completed
Review of the first year experience at SAC health system which may be the first federally funded qualified health care center (FQHS) based neurology clinics in the US: A retrospective study,
Role: Investigator,
LLU Dept. of Neurology,
(01/2018 - 12/2023)
Status: Completed